These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 5997594)

  • 1. [Antibiotic substances inducing the formation of mature phage particles in a lysogenic culture of Micrococcus lysodeikticus and their production by Actinomycetes].
    Terekhova LP
    Antibiotiki; 1966 Oct; 11(10):901-6. PubMed ID: 5997594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lysogenic conversion of antibiotic formation in Actinomyces leoris 2638].
    Rautenshteĭn IaI; Muradov M
    Izv Akad Nauk SSSR Biol; 1968; 4():575-9. PubMed ID: 5707056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the method of phage induction for the isolation and purification of antitumor antibiotics].
    Gauze GF; Terekhova LP; Kudinova MK; Rossolimo OK; Ukholina RS; Kovsharova IN; Nechaeva NP
    Antibiotiki; 1967 Mar; 12(3):179-83. PubMed ID: 4874765
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening of antineoplastic antibiotics by means of the phage induction method].
    Fadeeva NP; Terent'eva TG; Singal EM; Solov'eva NK; Efimova TN
    Antibiotiki; 1971 Mar; 16(3):236-9. PubMed ID: 5109159
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of lysogenic culture of Micrococcus lysodeikticus by antibiotics selectively affecting DNA synthesis.
    Dudnik YV
    Fed Proc Transl Suppl; 1965; 24(6):1049-51. PubMed ID: 4158678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lysogeny of the Streptomyces hygroscopicus culture reducing the antibiotic turimycin and some characteristics of its temperate phage].
    Rautenshteĭn IaI; Solov'eva NIa; Rot M; Noak D; Klaus Z
    Mikrobiologiia; 1976; 45(5):922-5. PubMed ID: 1004282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysogenic conversions of antibiotic formation in Actinomyces netropsis cultures].
    Muradov M; Rautenshteĭn IaI
    Mikrobiologiia; 1973; 42(2):327-31. PubMed ID: 4769922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of actinomycetes antagonists of the Azureus section].
    Preobrazhenskaia TP
    Antibiotiki; 1966 Sep; 11(9):849-61. PubMed ID: 5996880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antineoplastic antibiotic 4418 related to the antibiotics of the group pluramyciniomycin].
    Kudinova MK; Babenko GA; Ukholina RS; Maksimova TS; Nechaeva NP; Terekhova LP; Rossolimo OK
    Antibiotiki; 1968 Mar; 13(3):201-5. PubMed ID: 5672120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the variation in Actinomycetes producing antibiotics and other biologically active substances].
    Kuznetsov VD
    Antibiotiki; 1972 Jul; 17(7):666-71. PubMed ID: 4570083
    [No Abstract]   [Full Text] [Related]  

  • 11. [Culture-morphological and physiological properties of Actinomycetes no. 128--producer of antibiotic neothelomycin from the group of polypeptides].
    Stolpnik VG; Solov'eva IuV; Shilova IuG
    Antibiotiki; 1968 Jul; 13(7):621-30. PubMed ID: 5696457
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of mutation of T2 phage from h+ to h to screening of antitumor antibiotics produced by actinomycetes.
    Nakamura S; Omura S; Hamada M; Nishimura T; Yamaki H
    J Antibiot (Tokyo); 1967 Jul; 20(4):217-22. PubMed ID: 6072896
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lysogeny in heat-tolerant hydrocarbon-oxidizing actinomycetes of species Actinomyces griseomycini].
    Muradov M; Rautenshteĭn IaI; Akhmedova DU; Moskalenko LN
    Mikrobiologiia; 1975; 44(2):298-303. PubMed ID: 1226143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peculiarities of interaction of moderate actinophage, isolated from lysogenic culture of Act. spheroides 35 with different cultures--producers of novobiocin].
    Klenikova FS
    Antibiotiki; 1968 Jul; 13(7):588-94. PubMed ID: 5696452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of the use of Staphylococcus aureus 209 mutant UV-2 at different stages of screening of new antineoplastic antibiotics].
    Kochetkova GV; Il'chenko GB; Kovsharova IN
    Antibiotiki; 1970 Jul; 15(7):587-90. PubMed ID: 4097990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Obtaining of the phage resistant strain LS-V-241 Ph. R. Actinomyces orientalis].
    Deshits LA; Goldat SIu
    Antibiotiki; 1971 Jan; 16(1):50-3. PubMed ID: 5553277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systematic position, variability and antibiotic properties of the producer of antineoplastic antibiotic tavromycetin].
    Ivanitskaia LP; Upiter GD; Sveshnikova MA; Gauze GF
    Antibiotiki; 1966 Nov; 11(11):973-6. PubMed ID: 4871096
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the lysogeny of Act. levoris Krass--producer of the antifungal antibiotic levorin].
    Rautenshteĭn IaI; Zhukova RA; Filatova AD
    Antibiotiki; 1969 May; 14(5):390-4. PubMed ID: 5785938
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intracellular growth of actinophage in Actinomyces lividans culture lysogenic heat-induced mutant].
    Smirnova EI; Novikova NL
    Mikrobiologiia; 1976; 45():531-4. PubMed ID: 1004252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of a triene antibiotic by Actinomyces robefuscus Krasilnikov, Winogradova, 1960].
    Poltorak VA; Sokolova ZG; Vinogradova KA; Turchenko LV; Silaev AB
    Antibiotiki; 1974 Feb; 19(2):99-104. PubMed ID: 4463854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.